Twist Bioscience CORP Schedule 13G passive stakes

ARK Investment Management LLC and Catherine D. Wood have filed an amendment confirming their joint beneficial ownership of 7.31% of Twist Bioscience Corp. common stock as of June 30, 2026.

EdgePoint Investment Group Inc. has disclosed a beneficial ownership of 4.21% of Twist Bioscience Corp.'s common stock as of June 30, 2026.

Artisan Partners, through its various entities, has reported a beneficial ownership of 7.7% in Twist Bioscience Corporation's common shares as of June 30, 2026.

William Blair Investment Management, LLC has filed an amendment to its Schedule 13G, reporting its beneficial ownership of Twist Bioscience Corp. common stock as of June 30, 2026.

William Blair Investment Management, LLC has reported an 8.6% beneficial ownership stake in Twist Bioscience Corp.

Vanguard Capital Management has reported beneficial ownership of 5.05% of Twist Bioscience Corp.'s common stock as of March 31, 2026.

ARK Investment Management LLC and Catherine D. Wood have filed an amendment to their Schedule 13G, reporting beneficial ownership of 10.35% of Twist Bioscience Corp. common stock as of March 31, 2026.

The Vanguard Group filed an amended Schedule 13G, reporting 0% beneficial ownership in Twist Bioscience Corp following an internal realignment.

Artisan Partners Asset Management Inc. and its affiliates report a 10.1% beneficial ownership stake in Twist Bioscience Corporation common stock.

William Blair Investment Management, LLC has reported an increased beneficial ownership of 9.7% in Twist Bioscience Corp, holding 5,954,429 shares of common stock.

Artisan Partners Asset Management Inc. and its affiliates have reported a 9.5% beneficial ownership stake in Twist Bioscience Corporation as of December 31, 2025.

ARK Investment Management and Catherine D. Wood have filed an Amendment No. 7 to their Schedule 13G, disclosing a combined beneficial ownership of 12.36% in Twist Bioscience Corp.

EdgePoint Investment Group Inc. has disclosed a 6.76% beneficial ownership stake in Twist Bioscience Corp, holding over 4 million shares.

State Street Corporation has reported a 5.1% beneficial ownership stake in Twist Bioscience Corp, holding over 3 million common shares.

Artisan Partners Asset Management Inc. and its affiliates have reported a 10.6% beneficial ownership stake in Twist Bioscience Corporation, holding 6,410,900 common shares.

Artisan Partners Asset Management Inc. and its affiliates have reported a beneficial ownership of 8.4% in Twist Bioscience Corporation's common stock.

Invesco Ltd. has filed an amended Schedule 13G, reporting a 3.9% passive beneficial ownership stake in Twist Bioscience Corp.

William Blair Investment Management, LLC has disclosed a 6.4% beneficial ownership stake in Twist Bioscience Corp, holding 3,806,867 shares of common stock.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a passive beneficial ownership of 8.3% of Twist Bioscience Corp's common stock as of March 31, 2025.

ARK Investment Management LLC has disclosed a beneficial ownership of 10.70% in Twist Bioscience Corp, holding over 6.38 million shares as of February 28, 2025.

William Blair Investment Management, LLC has disclosed a 5.0% beneficial ownership stake in Twist Bioscience Corp, holding 2,949,723 shares of common stock as of December 31, 2024.

State Street Corporation has filed a Schedule 13G, reporting a 4.3% beneficial ownership stake in Twist Bioscience Corp as of December 31, 2024.

ARK Investment Management LLC has filed an amended Schedule 13G, revealing a beneficial ownership of 9.15% of Twist Bioscience Corp's common stock as of September 30, 2024.